Delivery Order SPE2DB25D3012-SPE2DB25FWWPE
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,514.77 Firm Fixed Price Delivery Order is for the supply of 4567760088 - NALBUPHINE 200 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,261.05, is a Firm Fixed Price Delivery Order for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML medical products. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,558.95 firm fixed-price delivery order contract is for the supply of NALBUPHINE 20 MG/ML AMPULML, a pharmaceutical product. The contract has a period of performance through February 20, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,067.69, is for the delivery of the medication Nalbuphine 10 mg/ml ampul. The contract is a firm fixed-price delivery order with a completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is a delivery order valued at $2,241.90 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for medical products, including "INJECTOR DRG DLV BD PHASEAL IV LL N35 LF", with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,811.50 firm fixed-price contract has a performance period through May 2, 2024, and supports the supply of various pharmaceutical and medical products, including specialty medications, generic drugs, vaccines, syringes, and other medical commodities. Amerisourcebergen holds a significant...
This federal contract award, valued at $2,724.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price for the procurement of 4567169725 ! SOL IRR BSS+ 500ML DISP items. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The $1,855.80 Firm Fixed Price contract has an ultimate completion date of July 24, 2024 and is not designated as a set-aside. This Delivery Order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDZU6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.80, is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 24, 2025. The contract covers the procurement of 4567335186 ! NALBUPHINE 10 MG/ML AMPULML, a medical product likely used for pain...